Temporal changes in stem cells in the circulation and myocardium of mice with Coxsackie virus B3-induced myocarditis

Microvascular Research

Volumn 75, Issue 3, 2008, Pages 358-366

  Zhao, Lan ^a,b   Li, Shuangjie ^a   Ge, Junbo ^b   Sun, Aijun ^b   Zou, Yunzeng ^b   Zhang, Shaoheng ^b  

^a UNIVERSITY OF SOUTH CHINA   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Proliferation; Stem cell; Viral myocarditis

Indexed keywords

COLLAGEN; CYTOPLASM PROTEIN; MYELOPEROXIDASE; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLEEDING; CELL LOSS; CELL PROLIFERATION; CONTROLLED STUDY; COXSACKIE VIRUS B3; FLOW CYTOMETRY; HEART MUSCLE; HEMATOPOIETIC STEM CELL; HISTOLOGY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INFECTION; INOCULATION; KINETICS; MALE; MESENCHYMAL STEM CELL; MICROSCOPY; MONONUCLEAR CELL; MOUSE; MUSCLE CELL; MYOCARDITIS; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; STAINING; STEM CELL; VASCULAR ENDOTHELIUM;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; CELL SEPARATION; CELLS, CULTURED; COLLAGEN; COXSACKIEVIRUS INFECTIONS; DISEASE MODELS, ANIMAL; ENTEROVIRUS B, HUMAN; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELLS; LEUKOCYTES, MONONUCLEAR; MALE; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED BALB C; MYOCARDITIS; MYOCARDIUM; MYOCYTES, CARDIAC; PEROXIDASE; REACTIVE OXYGEN SPECIES; TIME FACTORS;

ANIMALIA; COXSACKIEVIRUS; MUS;

EID: 41949097951     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2007.10.005     Document Type: Article

References (25)

1. Anversa P., and Nadal-Ginard B. Myocyte renewal and ventricular remodeling. Nature 415 (2002) 240-243
2. Assmus B., Honold J., Schachinger V., Britten M.B., Fischer-Rasokat U., Lehmann R., Teupe C., Pistorius K., Martin H., Abolmaali N.D., Tonn T., Dimmeler S., and Zeiher A.M. Transcoronary transplantation of progenitor cells after myocardial infarction. N. Engl. J. Med. 355 (2006) 1222-1232
3. Barile L., Messina E., Giacomello A., and Marbán E. Endogenous cardiac stem cells. Prog. Cardiovasc. Dis. 50 (2007) 31-48
4. Beltrami A.P., Urbanek K., Kajstura J., Yan S.M., Finato N., Bussani R., Nadal-Ginard B., Silvestri F., Leri A., Beltrami C.A., and Anversa P. Evidence that human cardiac myocytes divide after myocardial infarction. N. Engl. J. Med. 344 (2001) 1750-1757
5. Chan-Ling T., Baxter L., Afzal A., Sengupta N., Caballero S., Rosinova E., and Grant M.B. Hematopoietic stem cells provide repair functions after laser-induced Bruch's membrane rupture model of choroidal neovascularization. Am. J. Pathol. 168 (2006) 1031-1044
6. Chen X., Wilson R.M., Kubo H., Berretta R.M., Harris D.M., Zhang X., Jaleel N., MacDonnell S.M., Bearzi C., Tillmanns J., Trofimova I., Hosoda T., Mosna F., Cribbs L., Leri A., Kajstura J., Anversa P., and Houser S.R. Adolescent feline heart contains a population of small, proliferative ventricular myocytes with immature physiological properties. Circ. Res. 100 (2007) 536-544
7. De Falco E., Porcelli D., Torella A.R., Straino S., Iachininoto M.G., Orlandi A., Truffa S., Biglioli P., Napolitano M., Capogrossi M.C., and Pesce M. SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. Blood 104 (2004) 3472-3482
8. Dominici M., Blanc L.K., Mueller I., Slaper-Cortenbach I., Marini F., Krause D., Deans R., Keating A., Prockop D., and Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells, The International Society for Cellular Therapy position statement. Cytotherapy 8 (2006) 315-317
9. Feldman A.M., and McNamara D. N. Engl. J. Med. 343 (2000) 1388-1398
10. Gorin Y., Ricono J.M., Kim N.H., Bhandari B., Choudhury G.G., and Abboud H.E. Nox4 mediates angiotensin II-induced activation of Akt/protein kinase B in mesangial cells. Am. J. Physiol. 285 (2003) F219-F229
11. Hidemasa O.H., Steven B.B., Teresa D.G., Teruya N., Vinciane G., Yuji M., Jennifer P., Lloyd H.M., Richard R.B., Daniel J.G., Mark L.E., and Michael D.S. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 12313-12318
12. James T.N. Myocarditis and cardiomyopathy. N. Engl. J. Med. 308 (1983) 39-41
13. Kajstura J., Leri A., Finato N., Di Loreto C., Beltrami C.A., and Anversa P. Myocyte proliferation in end-stage cardiac failure in humans. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 8801-8805
14. Lauer B., Schannwell M., Kuhl U., Strauer B.E., and Schultheiss H.P. Antimyosin autoantibodies are associated with deterioration of systolic and diastolic left ventricular function in patients with chronic myocarditis. J. Am. Coll. Cardiol. 35 (2000) 11-18
15. + cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 433 (2005) 647-653
16. Liu P.P., and Mason J.W. Advances in the understanding of myocarditis. Circulation 104 (2001) 1076-1082
17. Meissner K., Heydrich B., Jedlitschky G., Meyer Z., Schwabedissen H., Mosyagin I., Dazert P., Eckel L., Vogelgesang S., Warzok R.W., Bohm M., Lehmann C., Wendt M., Cascorbi I., and Kroemer H.K. The ATP-binding cassette transporter ABCG2 (BCRP), a marker for side population stem cells, is expressed in human heart. J. Histochem. Cytochem. 54 (2006) 215-221
18. Meyer G.P., Wollert K.C., Lotz J., Steffens J., Lippolt P., Fichtner S., Hecker H., Schaefer A., Arseniev L., Hertenstein B., Ganser A., and Drexler H. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 113 (2006) 1287-1294
19. Minami E., Laflamme M.A., Saffitz J.E., and Murry C.E. Extracardiac progenitor cells repopulate most major cell types in the transplanted human heart. Circulation 112 (2005) 2951-2958
20. Nagaya N., Kangawa K., Itoh T., Iwase T., Murakami S., Miyahara Y., Fujii T., Uematsu M., Ohgushi H., Yamagishi M., Tokudome T., Mori H., Miyatake K., and Kitamura S. Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation 112 (2005) 1128-1135
21. Plttenger M.F., and Martin B.J. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ. Res. 95 (2004) 9-20
22. Torella D., Ellison G.M., Mendez-Ferrer S., Ibanez B., and Nadal-Ginard B. Resident human cardiac stem cells: role in cardiac cellular homeostasis and potential for myocardial regeneration. Nat. Clin. Pract. Cardiovasc. Med. 3 (2006) S8-S13
23. - cardiac progenitor cell population in postinfarction LV remodeling. Stem Cells 24 (2006) 1779-1788
24. Wang Y., Johnsen H.E., Mortensen S., Bindslev L., Ripa R.S., Haack-Sorensen M., Jorgensen E., Fang W., and Kastrup J. Changes in circulating mesenchymal stem cells, stem cell homing factor, and vascular growth factors in patients with acute ST elevation myocardial infarction treated with primary percutaneous coronary intervention. Heart 92 (2006) 768-774
25. Zhang S., Ge J., Sun A., Xu D., Qian J., Lin J., Zhao Y., Hu H., Li Y., Wang K., and Zou Y. Comparison of various kinds of bone marrow stem cells for the repair of infarcted myocardium: single clonally purified non-hematopoietic mesenchymal stem cells serve as a superior source. J. Cell. Biochem. 99 (2006) 1132-1147